| Product Code: ETC7640345 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Small Molecule Drug Discovery Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Small Molecule Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Small Molecule Drug Discovery Market - Industry Life Cycle |
3.4 Ireland Small Molecule Drug Discovery Market - Porter's Five Forces |
3.5 Ireland Small Molecule Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.6 Ireland Small Molecule Drug Discovery Market Revenues & Volume Share, By Process/Phase, 2021 & 2031F |
4 Ireland Small Molecule Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the pharmaceutical sector in Ireland. |
4.2.2 Growing prevalence of chronic diseases driving the demand for new small molecule drugs. |
4.2.3 Technological advancements in drug discovery processes leading to more efficient and cost-effective small molecule drug development. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes for new drugs. |
4.3.2 Limited availability of skilled professionals in the field of small molecule drug discovery. |
4.3.3 High costs associated with small molecule drug development and clinical trials. |
5 Ireland Small Molecule Drug Discovery Market Trends |
6 Ireland Small Molecule Drug Discovery Market, By Types |
6.1 Ireland Small Molecule Drug Discovery Market, By Therapeutic Area |
6.1.1 Overview and Analysis |
6.1.2 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Therapeutic Area, 2021- 2031F |
6.1.3 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.1.5 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.6 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.1.7 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F |
6.1.8 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.2 Ireland Small Molecule Drug Discovery Market, By Process/Phase |
6.2.1 Overview and Analysis |
6.2.2 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Target ID/Validation, 2021- 2031F |
6.2.3 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Hit Generation and Selection, 2021- 2031F |
6.2.4 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Lead Identification, 2021- 2031F |
6.2.5 Ireland Small Molecule Drug Discovery Market Revenues & Volume, By Lead Optimization, 2021- 2031F |
7 Ireland Small Molecule Drug Discovery Market Import-Export Trade Statistics |
7.1 Ireland Small Molecule Drug Discovery Market Export to Major Countries |
7.2 Ireland Small Molecule Drug Discovery Market Imports from Major Countries |
8 Ireland Small Molecule Drug Discovery Market Key Performance Indicators |
8.1 Number of new small molecule drug patents filed. |
8.2 Research and development expenditure in the small molecule drug discovery sector. |
8.3 Number of partnerships and collaborations in small molecule drug discovery research. |
8.4 Time taken from drug discovery to market launch. |
8.5 Success rate of small molecule drug candidates in clinical trials. |
9 Ireland Small Molecule Drug Discovery Market - Opportunity Assessment |
9.1 Ireland Small Molecule Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.2 Ireland Small Molecule Drug Discovery Market Opportunity Assessment, By Process/Phase, 2021 & 2031F |
10 Ireland Small Molecule Drug Discovery Market - Competitive Landscape |
10.1 Ireland Small Molecule Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Ireland Small Molecule Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here